ublituximab,teriflunomide
sanofi,tg therapeutics
['ublituximab', 'multiple sclerosis', '$xbi', 'tg therapeutics', '$ibb', '$tgtx', 'tgtherapeutics']
$tgtx tg therapeutics presents data from phase 3 trials of ublituximab for multiple sclerosis at aan 75th annual meeting #tgtherapeutics #ublituximab #multiplesclerosis #aan2023 more info: $xbi $ibb $xph $pph 
Latest BioPharma/Biotech News. Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  https://t.co/lvTtwarrGT